FBIO · Fortress Biotech, Inc. · Executive Compensation
Market Cap
$83.85M
Shares
36.78M
Volume · Oct 5
553.82K
Avg daily vol (3M)
513.41K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lucy Lu, M.D. | Chief Strategy Officer | Appointed | 2025-04-16 |
| Lucy Lu, M.D. | Board of Directors | Resigned | 2025-04-16 |
| Lucy Lu, M.D. | Director | Appointed | 2023-06-23 |
| Dov Klein, C.P.A. | Director | Appointed | 2023-06-23 |
| Malcolm Hoenlein | Director | Appointed | 2023-06-23 |
| Kevin L. Lorenz, J.D. | Director | Appointed | 2023-06-23 |
| Jimmie Harvey, Jr., M.D. | Director | Appointed | 2023-06-23 |
| J. Jay Lobell | Director | Appointed | 2023-06-23 |
| Eric R. Rowinsky, M.D. | Director | Appointed | 2023-06-23 |
| Michael S. Weiss | Director | Appointed | 2023-06-23 |
| Lindsay A. Rosenwald, M.D. | Director | Appointed | 2023-06-23 |
| Lucy Lu, M.D. | new member of the Board | Appointed | 2022-12-19 |
| David Jin | Chief Financial Officer | Appointed | 2022-07-22 |
| Robyn Hunter | Chief Financial Officer | Resigned | 2022-07-22 |